G. Gründer

642 total citations
9 papers, 219 citations indexed

About

G. Gründer is a scholar working on Molecular Biology, Pharmacology and Cellular and Molecular Neuroscience. According to data from OpenAlex, G. Gründer has authored 9 papers receiving a total of 219 indexed citations (citations by other indexed papers that have themselves been cited), including 2 papers in Molecular Biology, 2 papers in Pharmacology and 2 papers in Cellular and Molecular Neuroscience. Recurrent topics in G. Gründer's work include Neurotransmitter Receptor Influence on Behavior (2 papers), Functional Brain Connectivity Studies (2 papers) and Treatment of Major Depression (2 papers). G. Gründer is often cited by papers focused on Neurotransmitter Receptor Influence on Behavior (2 papers), Functional Brain Connectivity Studies (2 papers) and Treatment of Major Depression (2 papers). G. Gründer collaborates with scholars based in Germany and United States. G. Gründer's co-authors include Michael N. Smolka, Andreas Heinz, Gerald Reischl, Matthias Reimold, Anil Batra, Astrid Knobel, Christoph Solbach, Anke Zimmer, Roland Bares and Karl Mann and has published in prestigious journals such as Molecular Psychiatry, Psychopharmacology and Hormones and Behavior.

In The Last Decade

G. Gründer

8 papers receiving 211 citations

Peers

G. Gründer

CMN

CN

PHARM

PMH

BP

Laura E. Dennis United States

Mar Carceller‐Sindreu Spain

Nikolaus Thierry Austria

Astrid Knobel Germany

Nariko Katayama Japan

Viviana Tubazio Italy

Kerri A. Pierz United States

Laura Sutton United States

Shin-Chang Kuo Taiwan

Nicholas Murphy United States

Laura E. Dennis United States

G. Gründer

117 ×1.4

CMN

91 ×1.3

CN

32 ×0.5

PHARM

32 ×0.7

PMH

74 ×1.6

BP

Citations per year, relative to G. Gründer G. Gründer (= 1×) peers Laura E. Dennis

Countries citing papers authored by G. Gründer

Since Specialization

Citations

This map shows the geographic impact of G. Gründer's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by G. Gründer with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites G. Gründer more than expected).

Fields of papers citing papers by G. Gründer

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by G. Gründer. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by G. Gründer. The network helps show where G. Gründer may publish in the future.

Co-authorship network of co-authors of G. Gründer

This figure shows the co-authorship network connecting the top 25 collaborators of G. Gründer. A scholar is included among the top collaborators of G. Gründer based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with G. Gründer. G. Gründer is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

9 of 9 papers shown

1.

Hirjak, Dušan, et al.. (2022). Case series: Higher antipsychotic drug levels in patients with schizophrenia after COVID-19 vaccination. Pharmacopsychiatry. 55(3). 172–172. 1 indexed citations

2.

Schoretsanitis, Georgios, Ekkehard Haen, Benedikt Stegmann, et al.. (2016). Pharmacokinetic considerations of different dosing regimens in clozapine medicated patients. Pharmacopsychiatry. 49(3). 1 indexed citations

3.

Kienast, Thorsten, Florian Schlagenhauf, Michael A. Rapp, et al.. (2013). Dopamine-Modulated Aversive Emotion Processing Fails in Alcohol-Dependent Patients. Pharmacopsychiatry. 46(4). 130–136. 17 indexed citations

4.

Wagner, Michael, Svenja Schulze‐Rauschenbach, Nadine Petrovsky, et al.. (2012). Neurocognitive impairments in non-deprived smokers-results from a population-based multi-center study on smoking-related behavior. Addiction Biology. 18(4). 752–761. 48 indexed citations

5.

Koopmann, Anne, Christina Dinter, Martin Grosshans, et al.. (2011). Psychological and hormonal features of smokers at risk to gain weight after smoking cessation — Results of a multicenter study. Hormones and Behavior. 60(1). 58–64. 14 indexed citations

6.

Drueke, Barbara, et al.. (2009). Differential effects of escitalopram on attention: a placebo-controlled, double-blind cross-over study. Psychopharmacology. 207(2). 213–223. 23 indexed citations

7.

Reimold, Matthias, Anil Batra, Astrid Knobel, et al.. (2008). Anxiety is associated with reduced central serotonin transporter availability in unmedicated patients with unipolar major depression: a [11C]DASB PET study. Molecular Psychiatry. 13(6). 606–613. 99 indexed citations

8.

Reimold, Matthias, Anil Batra, Astrid Knobel, et al.. (2008). Reduced serotonin transporter availability in patients with unipolar major depression reflect the level of anxiety. Molecular Psychiatry. 13(6). 557–557. 16 indexed citations

9.

Davids, Eugen, et al.. (1998). Psychopharmakotherapie in Schwangerschaft und Stillzeit. Fortschritte der Neurologie · Psychiatrie. 66(5). 207–224.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact